Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C N Coupling. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111423405A details a novel Pd-catalyzed cross-dehydrogenative coupling route for benzopyran-3-ol derivatives, offering high yield and mild conditions for pharmaceutical intermediates.
Patent CN112939922A details a novel route for 1-cyano-6-methylsulfonyl-7-nitro-9H-xanthene-9-one, offering cost-effective manufacturing for mesotrione impurity standards.
Patent CN109963835B reveals a streamlined 2-step convergent synthesis for MMAF analogs, offering significant cost reduction in ADC manufacturing and enhanced supply chain reliability.
Patent CN111606894A reveals mild Ag-catalyzed C-H activation for ether alpha-position, offering cost-effective routes for drug synthesis.
Patent CN115583919B reveals a green photocatalytic route for high-purity pharmaceutical intermediates. Discover cost reduction and scalable supply chain advantages.
Patent CN108948077B details a green cobalt-catalyzed synthesis of alpha-phosphorylated amino acid esters using air oxidation, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
This report analyzes patent CN109761882A for Carprofen synthesis offering significant supply chain stability and cost reduction benefits for global veterinary pharmaceutical manufacturers.
Patent CN113754569A discloses a cost-effective route for Noxastota intermediates using mild carbonyl insertion, offering significant supply chain advantages.
Patent CN117210828B enables metal-free electrochemical thioglycoside synthesis. Offers high purity, reduced costs, and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN103772304A details a novel Cu-catalyzed synthesis for photoelectric materials, offering significant cost reduction and scalable manufacturing for high-performance OLED intermediates.
Patent CN109651344B reveals a copper-catalyzed green route for triarylmethanes. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN101563312A details a cost-effective route to Asenapine intermediates using 2-chlorophenylacetic acid, offering significant supply chain advantages for API manufacturers.
Patent CN112939922B details a cost-effective synthesis route for a critical Mesotrione impurity, offering reliable supply chain solutions and high-purity standards for agrochemical registration.
Patent CN113373466A details a green electrochemical route for beta-acetaminocarbonyl compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101475519B details a scalable route for NHE1 inhibitor intermediates, offering improved yields and supply chain reliability for cardiovascular drug manufacturing.
Patent CN111041515B reveals a metal-free electrochemical route for high-purity quinoxalinone intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102875444A details a Cu-catalyzed route for oxindoles. Offers high purity, mild conditions, and scalable manufacturing for pharma intermediates.
Patent CN114507180A reveals an iodine-catalyzed method for synthesizing bis-heteroaryl ethylenes with 90% yield, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN104447739B details deuterated Palbociclib derivatives enhancing bioavailability. We offer scalable synthesis for reliable API intermediate supply chains.
Novel Cu-Ni catalytic method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers seeking stable production.